Shuanglu Pharmaceutical: Director and Secretary to the Board Liang Shujie's reduction plan has been completed.

Shuanglu Pharmaceutical announced that its director and secretary of the board of directors, Liang Shujie, had previously planned to reduce their holdings by a centralized auction of up to 375,189 shares. Recently, the reduction plan was completed, with a total of 375,090 shares being sold on October 27 and November 4, 2025, accounting for 0.0365% of the total share capital, at an average price of 7.5454 yuan per share. After the reduction, Liang Shujie's shareholding decreased to 1,125,669 shares, accounting for 0.1096% of the total share capital. This reduction complies with relevant regulations and will not lead to a change in the company's controlling interest.